Yazar "Malkocoglu, Gulsah" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Detection of Hypervirulent ST-17 Clone Among Clinical Group B Streptococcus Isolates Using MALDI-TOF MS and PCR
    (Doc Design Informatics Co Ltd, 2025) Malkocoglu, Gulsah; Bulut, Mehmet Emin; Bayraktar, Banu; Otlu, Baris; Aktas, Elif
    Objective: Group B streptococcus (GBS) is the leading causative agent of neonatal morbidity and mortality. Sequence type 17 (ST-17) in GBS causes neonatal invasive disease more frequently than other STs. This study aimed to investigate the presence of hypervirulent ST-17 in a collection of clinical GBS isolates. Materials and Methods: GBS isolates obtained from patients with invasive and non-invasive infections were included in the study. For the detection of ST-17 GBS, matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) and polymerase chain reaction (PCR) methods were performed. Multilocus sequence typing (MLST) was also performed in a subset of some representative GBS strains. Results: Among 108 GBS isolates included in the study, 6 (5.5%) were identified as ST-17 by MALDI-TOF MS. Discriminatory peaks were detected at 7620 Da for ST-17 and 7638 Da for non-ST-17 isolates. In addition to six isolates that were positive for ST-17 by MALDI-TOF MS, one more isolate (GBS2) was found to be positive for ST-17 by PCR test. MLST revealed that those six isolates were ST-17 or single-locus variants of ST-17, while the isolate GBS2 was ST-1. Among the remaining 20 representative GBS isolates, 14 STs were identified by MLST, and all of them were non-ST-17 in accordance with MALDI-TOF MS and PCR results. Conclusion: In this study, the presence of a circulating hypervirulent ST-17 clone in T & uuml;rkiye was demonstrated for the first time. MALDI-TOF MS successfully and rapidly detected ST-17 and non-ST-17 GBS isolates. This practical method may contribute to efficiently managing neonatal infections caused by ST-17 GBS.
  • Küçük Resim Yok
    Öğe
    Evaluation of the Carbapenem Inactivation Method for Detection of Carbapenemase-Producing Gram-Negative Bacteria in Comparison with the RAPIDEC CARBA NP
    (Mary Ann Liebert, Inc, 2017) Aktas, Elif; Malkocoglu, Gulsah; Otlu, Baris; Cicek, Aysegul Copur; Kulah, Canan; Comert, Fusun; Sandalli, Cemal
    Timely detection of carbapenemases by both phenotypic and genotypic methods is essential for developing strategies to control the spread of infections by carbapenem-resistant isolates and related morbidity and mortality. The aim of this study was to compare the performance of a commercial kit, the RAPIDEC (R) CARBA NP, and an in-house technique, the carbapenem inactivation method (CIM), against a panel of 136 carbapenemase and noncarbapenemase-producing Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates. RAPIDEC CARBA NP displayed 99% sensitivity and 100% specificity, whereas the sensitivity and specificity were 78% and 100% for the CIM test, respectively. A slight modification of the CIM test, a prolonged incubation time of 4 hours instead of two, increased the sensitivity of the test to 90% by diminishing false negativity particularly for A. baumannii. In conclusion, both tests possess a high performance and are practical for the detection of carbapenemases. Although RAPIDEC CARBA NP is a more rapid and reliable method, the CIM test may represent a useful tool for microbiology laboratories due to its simplicity and availability at any laboratory with low cost.